Fischer Medical Ventures peers

Companies like Fischer Medical Ventureslatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FISCHER₹25.93

Fischer Medical Ventures Limited

· Pharma & Health
₹ CrorePeersTARSONSLAXMIDENTLFABTECHGKBMcap ₹1,697 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
FISCHER
FY26
TARSONS
FY26
LAXMIDENTL
FY26
FABTECH
FY26
Peer
Average
Valuation — at last close
P/E54.02×112.99×32.07×◆ 12.22×52.43× +3%
P/B4.42×2.55×4.01×◆ 1.29×2.62× +69%
EV/EBITDA40.51×16.74×21.97×◆ 10.50×16.41× +147%
Market Cap₹1,697 Cr₹1,617 Cr₹975 Cr₹543 Cr₹1,045 Cr +62%
Growth
Revenue YoY (latest Q)◆ 249.42%20.66%13.87%-24.20%3.44% +7144%
Net Income YoY (latest Q)-24.30%-180.99%◆ 23.83%-46.54%-67.90% +64%
Profitability
EBITDA Margin13.96%◆ 27.91%15.62%8.52%17.35% -20%
Net Income Margin10.05%3.39%◆ 10.41%9.34%7.71% +30%
Return on Common Equity8.07%2.26%◆ 12.83%9.14%8.08% 0%
Return on Capital Employed9.71%2.34%◆ 11.21%6.65%6.73% +44%
Return on Assets4.62%1.26%◆ 9.99%5.87%5.71% -19%
Credit & Quality
Total Debt/Equity0.19×0.60×◆ 0.00×0.10×0.23× -19%
Interest Coverage6.87×0.95×◆ 20.15×7.14×9.41× -27%
Scale — latest FY
Revenue / Total Income₹309 Cr₹423 Cr₹278 Cr₹411 Cr₹370 Cr -17%
Net Income₹31 Cr₹14.3 Cr₹28.9 Cr₹38.4 Cr₹27.2 Cr +14%
Total Assets₹671 Cr₹1,186 Cr₹294 Cr₹654 Cr₹711 Cr -6%
EPS₹0.48₹2.69₹5.53₹10₹6.07 -92%
Book Value per Share₹5.87₹119.29₹44.27₹94.43₹86 -93%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.